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Abstract
Background: Family history is considered an essential, obligatory part of the primary physician’s intake interview.
Including coded FH in a unified medical file can save expensive genetic tests and detect the early onset of diseases in
young people who are not recommended to be screened routinely. The objectives of this study are to explore the
frequency and point in time of recording the coded family history (FH) as a first step to increasing awareness of the
importance of such information.
Methods: All ICD-9 coded diagnoses of familial histories of disease (ICD-9 coded V16.0 – V19.8), including diseases related
to gender, age, and indications of chronic diseases, were collected from the electronic medical records of patients ages
18 and above in Israel’s Maccabi Health Care system. The study was carried out in 2012 on the basis of coded data for 1.9
million Maccabi members, which were collected from 2004 through 2011.
Results: Of the Maccabi members (the second biggest HMO in Israel covering 2 million people), only 10 % had FH coded
documentation. FH was significantly more frequent for females than for males (13.5 % vise 10.1 %) and increased with
age. About 10 % of the FH documentation occurred before any disease was diagnosed. The most frequent FH
documentation was observed for cardiovascular disease, hypertension, and diabetes. In the case of cancer FH was more
frequent in females, whereas in the case of males it was cardiovascular disease.
Discussion: Family history is an easy tool and need to be coded and implimented in most visits in order to get the best
information of the potential health and disease of the patients.
Conclusions: FH frequency is very low and varies with gender and age. The literature suggests that implementing it
routinely in primary care will improve health care. Further research is needed to identify the factors that impede primary
care givers from complying with FH guidelines.
Background
In the absence of affordable and accessible genomic exams
(known as "Omics"), the family history intake (FH) should
become a core element of clinical care, as it reflects shared
genetic, behavioral, and environmental factors and is a
means of eliciting stigmatizing information about suicide,
mental illness, alcoholism, sexual orientation, and past
trauma that patients might be reluctant to share [1]. Such
histories provide insights into health related behavior and
build a solid foundation of trust. However, while evidence
points to the utility of family health history screening,
providers still face difficulties in using this tool to make
clinical decisions [1]. Several studies show that physicians
often report that they collect family history information
[2, 3] and value its contribution [4], but other studies
using actual encounter data suggest that often family
history is either not obtained or is under utilized in risk
assessments [5–8]. Moreover, there is a paucity of litera-
ture about how family history information is captured in
primary care.
Maccabi Healthcare Services (MHS) is a large Israeli
health maintenance organization (HMO) providing primary
care services through approximately 3,000 solo practices to
1.9 million beneficiaries throughout the country in 2012.
MHS is a fully computerized organization. Information
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including patient records, billing systems, pharmaceutical
dispensations, and chronic disease registries is housed in
the organization’s central electronic warehouse DATA
BASE These automated datasets have been previously de-
scribed at length in previous studies [9–12]. During the
physician/nurse patient encounter, all of the information
collected is recorded electronically in either coded or free
text fields. However, there are no specific guidelines for the
collection and recording of the FH of the general public.
Furthermore, in most cases if a FH is queried, it happens
after the patient has been diagnosed with a chronic disease
(7). Currently, Maccabi physicians do not receive any finan-
cial incentives to document FH, nor does Maccabi engage
its physicians about their failure to do so.
Including FH in a unified medical file can save expensive
genetic tests and detect the early onset of diseases in young
people who are not recommended to be screened routinely
and those whose gender or unique characteristics put them
at risk for developing particular diseases. As a first step in
increasing awareness of the importance and usefulness of
FH information, the objective of this study was to explore
the habits of Israeli physicians regarding the recording of
coded family history. The search for FH was limited to
coded electronic fields. Free text was not evaluated, as only
coded FH is transferred to other medical staff. Our sample
group was MHS’s primary care physicians whom we
assessed with regard to their recording of the intervening
variables of the patient’s age, gender, and diagnosis.
Methods
We searched MHS' database for all information coded as
family history (ICD −9-CM codes: V16.0 – V19.8) for 1.9
patients ages 18 and over between the years 2004 and 2011.
We selected this time frame because in 2004 all of the phy-
sicians’ medical files were computerized. In addition, when
such information was documented, we searched the
chronic disease registries to investigate whether and when a
diagnosis was noted. Diagnoses were categorized into sev-
eral areas: cancer, cardiovascular disease (CVD), hyperten-
sion, diabetes, non-diabetes endocrine diseases, ophthalmic
illness, psychiatric disorders, and miscellaneous areas.
Demographic data included gender and age. Rates were cal-
culated with the disease sub-category as the denominator.
We looked for differences in gender because of the different
in disease pattern through life.
Results
Overall, only 12 % of MHS' members had coded FH
documentation in their electronic records. In all of the dis-
ease sub-categories, FH documentation was significantly
more frequent for females than for males (13.5 % vise
10.1 %). About 10 % of the FH documentation occurred be-
fore any disease was diagnosed. The most frequent FH
documentation was observed for CVD, hypertension, and
diabetes before the diagnosis of the diseases (Table 1).
FH documentation increased with the patient's age,
peaking at age 55–65 (Fig. 1). With regard to gender, we
observed that more females (40 %) received FH docu-
mentation when cancer was diagnosed than did males
(25 %). However, the opposite trend emerged for CVD
(13 % for females and 24 % for males) (Fig. 2).
Figure 3 presents the distribution of all FH documenta-
tion by diagnoses and age group. FH documentation with a
cancer diagnosis increased with age, whereas with a CVD
diagnosis the frequency of FH documentation remained al-
most steady.
Discussion
Our findings show the very infrequent documentation of
coded FH information for both male and female members
and for all disease sub-categories compared to other data
related by the patient. Indeed, the documentation of FH
with no diagnosis or prior to diagnosis occurred in only
10 % of the encounters between patients and physicians.
We found that more females (40 %) received FH docu-
mentation when cancer was diagnosed than did males
(25 %). However, the opposite trend emerged for CVD
(13 % for females and 24 % for males), maybe because of
gender differences in the prevalence of the disease.
Given the current absence of affordable and accessible
genetic tests and the immature state of clinical screen-
ing, a routine family history assessment may help iden-
tify those in primary care whose distinct familial disease
pattern might indicate an underlying genetic predispos-
ition that merits more extensive assessment [13]. Family
health history is currently the most applicable genomic
predictor for common, multifactor diseases, and can
also highlight patterns that suggest a strong inherited
susceptibility to a particular form of cancer or other
disease. Both bloodline ancestry and shared environ-
mental factors are important predictors of many dis-
eases [14], and are important for increasing awareness
about the risks of developing specific diseases, particu-
larly for metabolic conditions, among those who under-
estimate their risk [15]. Primary care practitioners can
also gain insight into patients' experiences of disease
Table 1 FHI rates by gender and main disease sub-categories [%]
Disease
sub-category
Male Female P value Total MHS
CVD 12,724 [19.8] 8,385 [20.5] 0.004 21,109 [20.1]
Cancer 3,652 [11.8] 6,441 [17.7] <0.001 10,093 [15%]
Hypertension 23,496 [19.8] 28,789 [22.8] <0.001 52,285 [21.4]
Diabetes 10,967 [21.1] 10,307 [23.1] <0.001 21,274 [22.0]
No Disease 65,358 [8.3] 97,277 [11.8] <0.001 162,635 [10.1]
All MHS 98,724 [10.1] 135,838 [13.5] <0.001 234,562 [12.0]
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within the family, which are relevant to framing pre-
ventive advice [13].
However, despite the fact that many health profes-
sionals regard family history enquiry as a standard elem-
ent of good medical care, and even when the disease is
well known to be associated with family history, physi-
cians often fail to collect such information [16, 17].
A study conducted in the US with Blue Cross and Blue
Shield found that prompting family physicians about
patients with family histories showing risks for six com-
mon conditions such as heart disease, stroke, diabetes,
and breast, colorectal, or ovarian cancer did not seem to
increase the identification or screening of these patients
[18]. In contrast to our finding, a meta-analysis of the
family history of cancer patients showed that physicians
paid more attention to the FH of patients free of cancer
than of those who were already suffering from the
disease [19].
Family history should be taken every few years begin-
ning with young people and updated frequently, because
details can change over time. Possible strategies for pro-
moting recording FH and updating it periodically in-
clude reminding the physician, other members of the
clinical staff, and/or the patient to do so.
Time constraints are cited as one of the factors that
limit the ability of physicians to comply with the recom-
mendation to collect such data, often leaving them unin-
formed about the family’s history or lifestyle factors [20].
In addition, until recently, computerized systems with
family history as an integral part of the patient’s medical
history and decision making had not yet been stan-
dardized or widely available in a structured fashion,
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Fig. 2 Prevalence of diagnosis of the family history in Maccabi HMS by gender
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Fig. 1 Percentage of the family history documentation by age group of the patients
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even though the U.S. Agency for Healthcare Research
and Quality’s (AHRQ) expert panel concluded that
systematic family history collection tools, some self-
administered, are likely to improve the usual practices
in primary care [21].
Another reason for the failure to collect FH is the abil-
ity of primary care physicians to interpret the informa-
tion. According to the AHRQ panel, “In practical terms,
the systematic collection of family history is linked with
the interpretation of that information which in turn is
linked to whether primary care providers take appropri-
ate clinical action on the basis of the information col-
lected” [21]. A qualitative study of 40 urban, suburban
and rural physicians who had graduated from medical
school between 1963 and 2000 noted that the doctors
regarded a family history of cancer as important, but
the process of obtaining this information and the con-
tent were not standardized. Major barriers to more fo-
cused use of this information included the limitations
of the patients' knowledge about their family’s medical
history, the time needed to clarify and interpret this
information, and the lack of clear and accessible guide-
lines to assist in the collection, interpretation and man-
agement decisions for average, moderate and higher
risk patients. In some populations, language and cul-
tural barriers also made it more difficult to collect fam-
ily histories [22].
The family history can be taken by any health profes-
sional if there is a united anamnesis medical file. Thus,
once an up-to-date family history is recorded, ideally,
decisions can be made that would help clinicians identify
which aspects of the family history are clinically relevant.
Using this data, health care professionals could deter-
mine the risk threshold that triggers earlier or more sen-
sitive screenings for cancer and other chronic diseases
or genetic evaluations for hereditary susceptibility to
cancer and other diseases [23–27]. On the other hand,
the collection of family history may also have the poten-
tial to increase the incidence of false-positive results and
test-associated complications that are costly and poten-
tially harmful [28, 29]. In times of limited resources, this
possibility may affect the guidelines of health organiza-
tions and clinical practices.
In MHS, FH documentation is not a mandatory com-
puter field, and the information is often written as free
text rather than coded, so it is unidentified by computer
algorithms. Moreover, given the absence of guidelines
for FH, the system cannot raise “red flags” that would
direct the physicians’ and other health staff ’s attention to
further inquiries into the family history.
Our results show that if FH was collected, it usually
happened when the patients were older and already had a
disease. However, FH is arguably more important for chil-
dren and young adults because it indicates risk factors for
illnesses such as cardiovascular disease and diabetes,
allowing preventive measures to be taken as early as pos-
sible. In health care organizations such as MHS in which
the family is a beneficiary unit, an electronic system link-
ing a parent's morbidity to his/her children could be a step
towards an efficient FH. Currently, in an effort to preserve
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the patient’s privacy, MHS follows a policy whereby physi-
cians cannot access the records of their patients’ relatives.
In addition, the family history should be discussed more
consistently with new patients as well as with well-
established patients [5]. To optimize the use of clinical
time and resources, it is important to know when to up-
date the family history of common diseases [29]. At this
point we suggest that family nurses, dietitians and other
health staff and the patients themselves by the personalize
health record should play an important role in collecting
FH and updating it once a year.
There are significant differences between female and
male patients in the process of care, and physicians may
be making medical decisions based on gender-related
considerations [16]. There is evidence that female
patients have longer visits, ask more questions, get more
information, receive more counseling, send and receive
more emotionally concerned statements, and appear
more involved in the interaction than male patients [30].
In our case, FH was more frequent among female pa-
tients than male patients. Strategies for implementing
knowledge about these gender differences are crucial for
the delivery of gender-sensitive care and FH collection.
Our study has a number of limitations. The search for
FH was limited to coded electronic fields. Free text was
not evaluated. Only the coded data are accessible by spe-
cialists, hospitals etc. and this is critical in the new era
of health information exchange. There may well be lots
of family history intake in the free text, and this could
be important for the primary care physicians' own use,
and would be a useful focus for another study. However,
it is not relevant to the current objectives which relate
to what FH information will be available to all caregivers
in the era.
Nevertheless, given the absence of an algorithm to as-
sess free text, we consider such information less useful,
unless the physician considered this information as valu-
able for the purposes for diagnosis. Furthermore, given
that our goal was to explore the frequency of the pres-
ence of FH as a first step in increasing awareness of the
importance of such information, we did not investigate
the factors associated with the low rates of collecting
family histories that are not coded. Such an investigation
should be the subject of further research. Another im-
portant issue is the cultural obstacles from reaching out
FH and there is a need to collaborate with other profes-
sions such as social workers in order to collect as much
FH data available.
Significance
The idea and findings in this paper are facing a big
challenge to make a necessary step that physicians
will obtain the family history of their patients. It can
be applied for teaching, service and research purposes
in healthcare management and education. It can also
serve as a benchmarking tool for education and prac-
tice. The FH inquiry developed and initially validated
in this study will contribute to fostering patient-
centered medicine by utilizing electronic medical re-
cords. Including FH in a unified medical file can save
expensive genetic tests and point to the early onset of
diseases such as breast cancer in young people who
are not recommended to be screened routinely. Raising
awareness about the importance of routine inquiry into
the patients and the current paucity of coded FH docu-
mentation’ family history may help improve their quality
of care.
Conclusions
The frequency of coded FH documentation is quite low
and varies according to age and gender. Further research
is needed to identify the factors that impede primary care
givers from complying with family history guidelines and
to assess the effectiveness various strategies for promoting
more frequent FH documentation as was found in this
study.
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